Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence

Immune checkpoint inhibitors (ICPIs) are considered one of the most important breakthroughs in cancer treatment of the past decade; notably, different studies of programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibitors have reported impressive clinical activity and dur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ther Adv Respir Dis
Hauptverfasser: Rihawi, Karim, Gelsomino, Francesco, Sperandi, Francesca, Melotti, Barbara, Fiorentino, Michelangelo, Casolari, Laura, Ardizzoni, Andrea
Format: Artigo
Sprache:Inglês
Veröffentlicht: SAGE Publications 2017
Schlagworte:
Reviews
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5933587/
https://ncbi.nlm.nih.gov/pubmed/28818019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465817725486
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge